1
|
Zowalla R, Pfeifer D, Wetter T. Readability and topics of the German Health Web: Exploratory study and text analysis. PLoS One 2023; 18:e0281582. [PMID: 36763573 PMCID: PMC9916670 DOI: 10.1371/journal.pone.0281582] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2022] [Accepted: 01/27/2023] [Indexed: 02/11/2023] Open
Abstract
BACKGROUND The internet has become an increasingly important resource for health information, especially for lay people. However, the information found does not necessarily comply with the user's health literacy level. Therefore, it is vital to (1) identify prominent information providers, (2) quantify the readability of written health information, and (3) to analyze how different types of information sources are suited for people with differing health literacy levels. OBJECTIVE In previous work, we showed the use of a focused crawler to "capture" and describe a large sample of the "German Health Web", which we call the "Sampled German Health Web" (sGHW). It includes health-related web content of the three mostly German speaking countries Germany, Austria, and Switzerland, i.e. country-code top-level domains (ccTLDs) ".de", ".at" and ".ch". Based on the crawled data, we now provide a fully automated readability and vocabulary analysis of a subsample of the sGHW, an analysis of the sGHW's graph structure covering its size, its content providers and a ratio of public to private stakeholders. In addition, we apply Latent Dirichlet Allocation (LDA) to identify topics and themes within the sGHW. METHODS Important web sites were identified by applying PageRank on the sGHW's graph representation. LDA was used to discover topics within the top-ranked web sites. Next, a computer-based readability and vocabulary analysis was performed on each health-related web page. Flesch Reading Ease (FRE) and the 4th Vienna formula (WSTF) were used to assess the readability. Vocabulary was assessed by a specifically trained Support Vector Machine classifier. RESULTS In total, n = 14,193,743 health-related web pages were collected during the study period of 370 days. The resulting host-aggregated web graph comprises 231,733 nodes connected via 429,530 edges (network diameter = 25; average path length = 6.804; average degree = 1.854; modularity = 0.723). Among 3000 top-ranked pages (1000 per ccTLD according to PageRank), 18.50%(555/3000) belong to web sites from governmental or public institutions, 18.03% (541/3000) from nonprofit organizations, 54.03% (1621/3000) from private organizations, 4.07% (122/3000) from news agencies, 3.87% (116/3000) from pharmaceutical companies, 0.90% (27/3000) from private bloggers, and 0.60% (18/3000) are from others. LDA identified 50 topics, which we grouped into 11 themes: "Research & Science", "Illness & Injury", "The State", "Healthcare structures", "Diet & Food", "Medical Specialities", "Economy", "Food production", "Health communication", "Family" and "Other". The most prevalent themes were "Research & Science" and "Illness & Injury" accounting for 21.04% and 17.92% of all topics across all ccTLDs and provider types, respectively. Our readability analysis reveals that the majority of the collected web sites is structurally difficult or very difficult to read: 84.63% (2539/3000) scored a WSTF ≥ 12, 89.70% (2691/3000) scored a FRE ≤ 49. Moreover, our vocabulary analysis shows that 44.00% (1320/3000) web sites use vocabulary that is well suited for a lay audience. CONCLUSIONS We were able to identify major information hubs as well as topics and themes within the sGHW. Results indicate that the readability within the sGHW is low. As a consequence, patients may face barriers, even though the vocabulary used seems appropriate from a medical perspective. In future work, the authors intend to extend their analyses to identify trustworthy health information web sites.
Collapse
Affiliation(s)
- Richard Zowalla
- Department of Medical Informatics, Heilbronn University, Heilbronn, Germany
- Center for Machine Learning, Heilbronn University, Heilbronn, Germany
- * E-mail:
| | - Daniel Pfeifer
- Department of Medical Informatics, Heilbronn University, Heilbronn, Germany
- Center for Machine Learning, Heilbronn University, Heilbronn, Germany
| | - Thomas Wetter
- Institute of Medical Informatics, Heidelberg University Hospital, Heidelberg, Germany
- Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, Washington, United States of America
| |
Collapse
|
2
|
Strüßmann T, Wäsch R, Scherer F, Mutter JA, Pfeifer D, Bartsch I, Giesler S, Graziani G, Duyster J, Finke J, Marks R. A patient with refractory high-grade B-cell lymphoma and rapid progression under CAR-T-cell therapy was successfully salvaged with inotuzumab- ozogamicin. Leuk Lymphoma 2022; 63:2260-2262. [DOI: 10.1080/10428194.2022.2074991] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- T. Strüßmann
- Department of Medicine I, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - R. Wäsch
- Department of Medicine I, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - F. Scherer
- Department of Medicine I, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
- German Cancer Consortium (DKTK) partner site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - J. A. Mutter
- Department of Medicine I, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
- Faculty of Biology, University of Freiburg, Freiburg, Germany
| | - D. Pfeifer
- Department of Medicine I, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - I. Bartsch
- Department of Medicine I, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - S. Giesler
- Department of Medicine I, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - G. Graziani
- Department of Medicine I, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - J. Duyster
- Department of Medicine I, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - J. Finke
- Department of Medicine I, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - R. Marks
- Department of Medicine I, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| |
Collapse
|
3
|
Dederichs TS, Ehlert C, Becker H, Pfeifer D, Bode C, Hilgendorf I. Chip mutations mediate human atherosclerosis by activating monocyte pro-inflammatory pathways without evidently promoting monocyte chemotaxis. Atherosclerosis 2021. [DOI: 10.1016/j.atherosclerosis.2021.06.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
4
|
Salabura P, Adamczewski-Musch J, Arnoldi-Meadows B, Belounnas A, Belyaev A, Blanco A, Blume C, Böhmer M, Borisenko S, Chlad L, Chudoba P, Ciepał I, Dittert D, Dreyer J, Esmail W, Dürr M, Fabbietti L, Fateev S, Fonte P, Friese J, Fröhlich I, Förtsch J, Galatyuk T, Gernhäuser R, Golosov O, Golubeva M, Greifenhagen R, Guber F, Gumberidze M, Harabasz S, Hensch R, Höhne C, Holzmann R, Huck H, Ierusalimov A, Ivashkin A, Kämpfer B, Kampert KH, Kardan B, Koenig I, Koenig W, Kornakov G, Kornas F, Kotte R, Kozela A, Kres I, Kuboś J, Kugler A, Kulesa P, Ladygin V, Lalik R, Lebedev A, Lebedev S, Linev S, Lopes L, Lorenz M, Lykasov G, Mahmoud T, Malige A, Markert J, Matulewicz T, Maurus S, Metag V, Michel J, Morozov S, Müntz C, Naumann L, Nowakowski K, Otto JH, Patel V, Pauly C, Pechenov V, Pechenova O, Petukhov O, Pfeifer D, Piasecki K, Pietraszko J, Prozorov A, Przygoda W, Pysz K, Ramstein B, Rathod N, Reshetin A, Ritman L, Rodriguez-Ramos P, Rost A, Salabura P, Scozzi F, Seck F, Selyuzhenkov I, Shabanov I, Singh US, Smyrski J, Spies S, Ströbele H, Stroth J, Stumm J, Svoboda O, Szala M, Tlusty P, Traxler M, Ungethüm C, Vazquez-Doce O, Wagner V, Weber A, Wendisch C, Wiebusch M, Wintz P, Wirth J, Zhilin A, Zumbruch P. Exploring time like tranistions in pp, πp and AA reactions with HADES. EPJ Web Conf 2020. [DOI: 10.1051/epjconf/202024101013] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Radiative transition of an excited baryon to a nucleon with emission of a virtual massive photon converting to dielectron pair (Dalitz decays) provides important information about baryon-photon coupling at low q2 in timelike region. A prominent enhancement in the respective electromagnetic transition Form Factors (etFF) at q2 near vector mesons ρ/ω poles has been predicted by various calculations reflecting strong baryon-vector meson couplings. The understanding of these couplings is also of primary importance for the interpretation of the emissivity of QCD matter studied in heavy ion collisions via dilepton emission. Dedicated measurements of baryon Dalitz decays in proton-proton and pion-proton scattering with HADES detector at GSI/FAIR are presented and discussed. The relevance of these studies for the interpretation of results obtained from heavy ion reactions is elucidated on the example of the HADES results.
Collapse
|
5
|
Zowalla R, Wetter T, Pfeifer D. Crawling the German Health Web: Exploratory Study and Graph Analysis. J Med Internet Res 2020; 22:e17853. [PMID: 32706701 PMCID: PMC7414401 DOI: 10.2196/17853] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2020] [Revised: 03/25/2020] [Accepted: 05/14/2020] [Indexed: 12/27/2022] Open
Abstract
BACKGROUND The internet has become an increasingly important resource for health information. However, with a growing amount of web pages, it is nearly impossible for humans to manually keep track of evolving and continuously changing content in the health domain. To better understand the nature of all web-based health information as given in a specific language, it is important to identify (1) information hubs for the health domain, (2) content providers of high prestige, and (3) important topics and trends in the health-related web. In this context, an automatic web crawling approach can provide the necessary data for a computational and statistical analysis to answer (1) to (3). OBJECTIVE This study demonstrates the suitability of a focused crawler for the acquisition of the German Health Web (GHW) which includes all health-related web content of the three mostly German speaking countries Germany, Austria and Switzerland. Based on the gathered data, we provide a preliminary analysis of the GHW's graph structure covering its size, most important content providers and a ratio of public to private stakeholders. In addition, we provide our experiences in building and operating such a highly scalable crawler. METHODS A support vector machine classifier was trained on a large data set acquired from various German content providers to distinguish between health-related and non-health-related web pages. The classifier was evaluated using accuracy, recall and precision on an 80/20 training/test split (TD1) and against a crowd-validated data set (TD2). To implement the crawler, we extended the open-source framework StormCrawler. The actual crawl was conducted for 227 days. The crawler was evaluated by using harvest rate and its recall was estimated using a seed-target approach. RESULTS In total, n=22,405 seed URLs with country-code top level domains .de: 85.36% (19,126/22,405), .at: 6.83% (1530/22,405), .ch: 7.81% (1749/22,405), were collected from Curlie and a previous crawl. The text classifier achieved an accuracy on TD1 of 0.937 (TD2=0.966), a precision on TD1 of 0.934 (TD2=0.954) and a recall on TD1 of 0.944 (TD2=0.989). The crawl yields 13.5 million presumably relevant and 119.5 million nonrelevant web pages. The average harvest rate was 19.76%; recall was 0.821 (4105/5000 targets found). The resulting host-aggregated graph contains 215,372 nodes and 403,175 edges (network diameter=25; average path length=6.466; average degree=1.872; average in-degree=1.892; average out-degree=1.845; modularity=0.723). Among the 25 top-ranked pages for each country (according to PageRank), 40% (30/75) were web sites published by public institutions. 25% (19/75) were published by nonprofit organizations and 35% (26/75) by private organizations or individuals. CONCLUSIONS The results indicate, that the presented crawler is a suitable method for acquiring a large fraction of the GHW. As desired, the computed statistical data allows for determining major information hubs and important content providers on the GHW. In the future, the acquired data may be used to assess important topics and trends but also to build health-specific search engines.
Collapse
Affiliation(s)
- Richard Zowalla
- Department of Medical Informatics, Heilbronn University, Heilbronn, Germany.,Center for Machine Learning, Heilbronn University, Heilbronn, Germany
| | - Thomas Wetter
- Institute of Medical Biometry and Informatics, Heidelberg University, Heidelberg, Germany.,Institute of Software and Information Systems Engineering, Ben-Gurion University of the Negev, Beer Sheva, Israel.,Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, United States
| | - Daniel Pfeifer
- Department of Medical Informatics, Heilbronn University, Heilbronn, Germany.,Center for Machine Learning, Heilbronn University, Heilbronn, Germany
| |
Collapse
|
6
|
Ramstein B, Adamczewski-Musch J, Arnold O, Arnoldi-Meadows B, Belounnas A, Belyaev A, Biernat J, Blanco A, Blume C, Böhmer M, Bordalo P, Chlad L, Chudoba P, Ciepał I, Deveaux C, Dittert D, Dreyer J, Fabbietti L, Fateev O, Fonte P, Franco C, Friese J, Fröhlich I, Galatyuk T, Garzón JA, Gernhäuser R, Gillitzer A, Golubeva M, Greifenhagen R, Guber F, Gumberidze M, Harabasz S, Heinz T, Hennino T, Himmelreich M, Höhne C, Holzmann R, Ierusalimov A, Ivanov V, Ivashkin A, Kämpfer B, Kajetanowicz M, Kampert KH, Karavicheva T, Kardan B, Khomyakov V, Koenig I, Koenig W, Korcyl G, Kornakov G, Kornas F, Kotte R, Kozela A, Kuboś J, Kugler A, Kunz T, Kurepin A, Kurilkin P, Kushpil V, Ladygin V, Lalik R, Lebedev A, Linev S, Liu M, Lopes L, Lorenz M, Lykasov G, Mahmoud T, Malakhov A, Markert J, Maurus S, Metag V, Michel J, Mihaylov D, Mikhaylov V, Morozov S, Müntz C, Naumann L, Nowakowski K, Parpottas Y, Patel V, Pauly C, Pechenov V, Pechenova O, Pereira A, Petousis V, Petukhov O, Pfeifer D, Pietraszko J, Przygoda W, Pysz K, Ramos S, Reshetin A, Ritman L, Rodriguez-Ramos P, Rost A, Sadovsky A, Salabura P, Scheib T, Schuldes H, Schwab E, Scozzi F, Seck F, Sellheim P, Selyuzhenkov I, Silva L, Smyrski J, Sobiella M, Spataro S, Spies S, Ströbele H, Stroth J, Strzempek P, Svoboda O, Szala M, Taranenko A, Tlusty P, Traxler M, Troyan A, Tsertos H, Wagner V, Wendisch C, Wiebusch M, Wintz P, Wirth J, Włoch B, Zhilin A, Zinchenko A, Zumbruch P, Zuschke M. Time-Like Baryon Transitions studies with HADES. EPJ Web Conf 2019. [DOI: 10.1051/epjconf/201919901008] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
The HADES collaboration uses the e+e− production as a probe of the resonance matter produced in collisions at incident energies of 1-3.5 GeV/nucleon at GSI. Elementary reactions provide useful references for these studies and give information on resonance Dalitz decays (R→Ne+e−). Such processes are sensitive to the structure of time-like electromagnetic baryon transitions in a kinematic range where (off-shell) vector mesons play a crucial role. Results obtained in proton-proton reactions and in a commissioning pion-beam experiment are reported and prospects for future pion beam experiments and for first hyperon Dalitz decay measurements are described. The connection with the investigations of medium effects to be continued with HADES in the next years at SIS18 and SIS100 is also discussed.
Collapse
|
7
|
Adamczewski-Musch J, Akishin P, Becker K, Bendarouach J, Deveaux C, Dürr M, Eschke J, Förtsch J, Heep J, Höhne C, Ivanishchev D, Kampert K, Kochenda L, Kravtsov P, Kres I, Lebedev S, Lebedeva E, Linev S, Mahmoud T, Malaev M, Michel J, Miftakhov N, Niebur W, Otto J, Ovcharenko E, Patel V, Pauly C, Pfeifer D, Riabov Y, Roshchin E, Samsonov V, Tarasenkova O, Traxler M, Tyts D, Vznuzdaev M, Weber A, Zumbruch P. Event reconstruction of free-streaming data for the RICH detector in the CBM experiment. EPJ Web Conf 2019. [DOI: 10.1051/epjconf/201921401043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
The Compressed Baryonic Matter (CBM) experiment is a dedicated heavy ion collision experiment at the FAIR facility. It will be one of the first HEP experiments which works in a triggerless mode: data received in the DAQ
from the detectors will not be associated with events by a hardware trigger anymore. All raw data within a giventime period will be collected continuously in containers, so-called time-slices. The task of the reconstruction algorithms is to create events out of this raw data stream. In this contribution, the optimization of the reconstruction software in the RICH detector to the free-streaming data flow is presented. The implementation of ring reconstruction algorithms which use time measurements of the hits as an additional parameter is discussed.
Collapse
|
8
|
Fricke A, Cimniak A, Ullrich P, Becherer C, Bickert C, Pfeifer D, Heinz J, Stark G, Bannasch H, Braig D, Eisenhardt S. Whole blood miRNA expression analysis reveals miR-3613-3p as a potential biomarker for dedifferentiated liposarcoma. Cancer Biomark 2018; 22:199-207. [DOI: 10.3233/cbm-170496] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Affiliation(s)
- A. Fricke
- Department of Plastic and Hand Surgery, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - A.F.V. Cimniak
- Department of Plastic and Hand Surgery, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - P.V. Ullrich
- Department of Plastic and Hand Surgery, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - C. Becherer
- Department of Plastic and Hand Surgery, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - C. Bickert
- Department of Plastic and Hand Surgery, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - D. Pfeifer
- Department of Hematology, Oncology and Stem Cell Transplantation, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - J. Heinz
- Department of Hematology, Oncology and Stem Cell Transplantation, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - G.B. Stark
- Department of Plastic and Hand Surgery, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - H. Bannasch
- Department of Plastic and Hand Surgery, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - D. Braig
- Department of Plastic and Hand Surgery, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - S.U. Eisenhardt
- Department of Plastic and Hand Surgery, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| |
Collapse
|
9
|
Turner AM, Facelli JC, Jaspers M, Wetter T, Pfeifer D, Gatewood LC, Adam T, Li Y, Lin MC, Evans RS, Beukenhorst A, Theodoore van Mens HJ, Tensen E, Bock C, Fendrich L, Seitz P, Suleder J, Aldekhyyel R, Bridgeman K, Hu Z, Sattler A, Guo SY, Mohaimenul IM, Anggraini Ningrum DN, Tung HR, Bian J, Plasek JM, Rommel C, Burke J, Sohi H. Solving Interoperability in Translational Health. Perspectives of Students from the International Partnership in Health Informatics Education (IPHIE) 2016 Master Class. Appl Clin Inform 2017; 8:651-659. [PMID: 28636063 PMCID: PMC6241746 DOI: 10.4338/aci-2017-01-cr-0012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2017] [Accepted: 04/14/2017] [Indexed: 11/23/2022] Open
Abstract
BACKGROUND In the summer of 2016 an international group of biomedical and health informatics faculty and graduate students gathered for the 16th meeting of the International Partnership in Health Informatics Education (IPHIE) masterclass at the University of Utah campus in Salt Lake City, Utah. This international biomedical and health informatics workshop was created to share knowledge and explore issues in biomedical health informatics (BHI). OBJECTIVE The goal of this paper is to summarize the discussions of biomedical and health informatics graduate students who were asked to define interoperability, and make critical observations to gather insight on how to improve biomedical education. METHODS Students were assigned to one of four groups and asked to define interoperability and explore potential solutions to current problems of interoperability in health care. RESULTS We summarize here the student reports on the importance and possible solutions to the "interoperability problem" in biomedical informatics. Reports are provided from each of the four groups of highly qualified graduate students from leading BHI programs in the US, Europe and Asia. CONCLUSION International workshops such as IPHIE provide a unique opportunity for graduate student learning and knowledge sharing. BHI faculty are encouraged to incorporate into their curriculum opportunities to exercise and strengthen student critical thinking to prepare our students for solving health informatics problems in the future.
Collapse
Affiliation(s)
- Anne M. Turner
- Department of Biomedical Informatics and Medical Education, University of Washington
| | - Julio C. Facelli
- Department of Biomedical Informatics, University of Utah and Intermountain Healthcare
| | | | - Thomas Wetter
- Department of Medical Informatics, University of Heidelberg, Heidelberg, Germany
| | - Daniel Pfeifer
- Department of Information Technology, Hochschule Heilbronn, Heilbronn, Germany
| | | | - Terry Adam
- Institute for Health Informatics, University of Minnesota
| | - YuChuan Li
- Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
| | - Ming-Chin Lin
- Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
| | - R. Scott Evans
- Department of Biomedical Informatics, University of Utah and Intermountain Healthcare
| | | | | | - Esmée Tensen
- Amsterdam Medical Center, Amsterdam, Netherlands
| | - Christian Bock
- Department of Medical Informatics, University of Heidelberg, Heidelberg, Germany
| | - Laura Fendrich
- Department of Medical Informatics, University of Heidelberg, Heidelberg, Germany
| | - Peter Seitz
- Department of Medical Informatics, University of Heidelberg, Heidelberg, Germany
| | - Julian Suleder
- Department of Medical Informatics, University of Heidelberg, Heidelberg, Germany
| | | | - Kent Bridgeman
- Institute for Health Informatics, University of Minnesota
| | - Zhen Hu
- Institute for Health Informatics, University of Minnesota
| | - Aaron Sattler
- Institute for Health Informatics, University of Minnesota
| | - Shin-Yi Guo
- Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
| | - Islam Md. Mohaimenul
- Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
| | - Dina Nur Anggraini Ningrum
- Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
| | - Hsin-Ru Tung
- Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
| | - Jiantao Bian
- Department of Biomedical Informatics, University of Utah and Intermountain Healthcare
| | - Joseph M. Plasek
- Department of Biomedical Informatics, University of Utah and Intermountain Healthcare
| | - Casey Rommel
- Department of Biomedical Informatics, University of Utah and Intermountain Healthcare
| | - Juandalyn Burke
- Department of Biomedical Informatics and Medical Education, University of Washington
| | - Harkirat Sohi
- Department of Biomedical Informatics and Medical Education, University of Washington
| |
Collapse
|
10
|
Stickel N, Hanke K, Marschner D, Prinz G, Köhler M, Melchinger W, Pfeifer D, Schmitt-Graeff A, Brummer T, Heine A, Brossart P, Wolf D, von Bubnoff N, Finke J, Duyster J, Ferrara J, Salzer U, Zeiser R. MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT signaling in dendritic cells after stem cell transplantation. Leukemia 2017; 31:2732-2741. [PMID: 28484267 PMCID: PMC6231537 DOI: 10.1038/leu.2017.137] [Citation(s) in RCA: 79] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2017] [Revised: 04/13/2017] [Accepted: 04/24/2017] [Indexed: 02/07/2023]
Abstract
Acute Graft-versus-host disease (GVHD) is a major immunological complication after allogeneic hematopoietic cell transplantation and a better understanding of the molecular regulation of the disease could help to develop novel targeted therapies. Here we found that a G/C polymorphism within the human microRNA-146a (miR-146a) gene of transplant-recipients, which causes reduced miR-146a levels, was strongly associated with the risk of developing severe acute GVHD (n=289). In mice, deficiency of miR-146a in the hematopoietic system or transfer of recipient-type miR 146a-/- dendritic cells (DCs) enhanced GVHD, while miR-146a mimic-transfected-DCs ameliorated disease. Mechanistically, lack of miR-146a enhanced JAK2 STAT1-pathway activity, which led to higher expression of class II-transactivator (CIITA) and consecutively increased MHCII-levels on DCs. Inhibition of JAK1/2 or CIITA knockdown in DCs prevented miR-146a-/- DC-induced GVHD exacerbation. Consistent with our findings in mice, patients with the miR-146a polymorphism rs2910164 in hematopoietic cells displayed higher MHCII levels on monocytes, which could be targeted by JAK1/2-inhibition. Our findings indicate that the miR-146a polymorphism rs2910164 identifies patients at high risk for GVHD before allo HCT. Functionally we show that miR-146a acts as a central regulator of recipient-type DC activation during GVHD by dampening the pro-inflammatory JAK-STAT/CIITA/MHCII axis, which provides a scientific rationale for early JAK1/2-inhibition in selected patients.
Collapse
Affiliation(s)
- N Stickel
- Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany.,Spemann Graduate School of Biology and Medicine, ALU Freiburg, Germany.,Faculty of Biology, ALU Freiburg, Germany
| | - K Hanke
- Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany.,Faculty of Biology, ALU Freiburg, Germany
| | - D Marschner
- Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - G Prinz
- Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - M Köhler
- Spemann Graduate School of Biology and Medicine, ALU Freiburg, Germany.,Faculty of Biology, ALU Freiburg, Germany.,Signal Transduction in Tumour Development and Drug Resistance Group, Institute of Molecular Medicine and Cell Research (IMMZ), ALU Freiburg, Germany
| | - W Melchinger
- Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - D Pfeifer
- Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - A Schmitt-Graeff
- Department of Pathology, Freiburg University Medical Center, ALU Freiburg, Germany
| | - T Brummer
- Signal Transduction in Tumour Development and Drug Resistance Group, Institute of Molecular Medicine and Cell Research (IMMZ), ALU Freiburg, Germany.,Centre for Biological Signaling Studies BIOSS, ALU Freiburg, Germany
| | - A Heine
- Medical Clinic III, Oncology, Hematology and Rheumatology, University Hospital Bonn (UKB), Bonn, Germany
| | - P Brossart
- Medical Clinic III, Oncology, Hematology and Rheumatology, University Hospital Bonn (UKB), Bonn, Germany
| | - D Wolf
- Medical Clinic III, Oncology, Hematology and Rheumatology, University Hospital Bonn (UKB), Bonn, Germany
| | - N von Bubnoff
- Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany.,German Cancer Consortium (DKTK), Freiburg, Germany.,German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - J Finke
- Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - J Duyster
- Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - J Ferrara
- Department of Medicine, Hematology and Medical Oncology, Mount Sinai Hospital, New York, NY, USA
| | - U Salzer
- Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Germany.,Department of Rheumatology and Clinical Immunology, University Medical Center Freiburg, Germany
| | - R Zeiser
- Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany.,Centre for Biological Signaling Studies BIOSS, ALU Freiburg, Germany.,German Cancer Consortium (DKTK), Freiburg, Germany.,German Cancer Research Center (DKFZ), Heidelberg, Germany
| |
Collapse
|
11
|
Radeglia R, Pfeifer D. Ein einfaches kinetisches Modell zur Beschreibung von CIDNP-Effekten. Z PHYS CHEM 2017. [DOI: 10.1515/zpch-1985-26660] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
12
|
Heiland DH, Pfeifer D, Mader I, Weyerbrock A. P07.10 Integrative Network-based Analysis links Vessel-Size Imaging (VSI) and Cerebral Blood Volume (CBV) to specific Molecular Patterns in Malignant Gliomas. Neuro Oncol 2016. [DOI: 10.1093/neuonc/now188.121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
13
|
Muscat M, Shefer A, Ben Mamou M, Spataru R, Jankovic D, Deshevoy S, Butler R, Pfeifer D. Corrigendum to ‘The state of measles and rubella in the WHO European Region, 2013’ [Clin Microbiol Infect 20 (Suppl. 5) (2014), pp. 12–18]. Clin Microbiol Infect 2015. [DOI: 10.1016/j.cmi.2014.12.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
14
|
Rurik C, Zowalla R, Wiesner M, Pfeifer D. Proactive Support of Internet Browsing when Searching for Relevant Health Information. Stud Health Technol Inform 2015; 213:95-98. [PMID: 26152963] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
Many people use the Internet as one of the primary sources of health information. This is due to the high volume and easy access of freely available information regarding diseases, diagnoses and treatments. However, users may find it difficult to retrieve information which is easily understandable and does not require a deep medical background. In this paper, we present a new kind of Web browser add-on, in order to proactively support users when searching for relevant health information. Our add-on not only visualizes the understandability of displayed medical text but also provides further recommendations of Web pages which hold similar content but are potentially easier to comprehend.
Collapse
Affiliation(s)
- Clas Rurik
- Dept. of Information and Media, Heilbronn University, Heilbronn, Germany
| | - Richard Zowalla
- Dept. of Medical Informatics, Heilbronn University, Heilbronn, Germany
| | - Martin Wiesner
- Dept. of Medical Informatics, Heilbronn University, Heilbronn, Germany
| | - Daniel Pfeifer
- Dept. of Information and Media, Heilbronn University, Heilbronn, Germany
| |
Collapse
|
15
|
Zowalla R, Wiesner M, Pfeifer D. Expertizer: a tool to assess the expert level of online health websites. Stud Health Technol Inform 2015; 210:10-14. [PMID: 25991092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
Health-related Web sites have become a primary resource to search for information on diseases, diagnoses or treatment options. Various Web sites offer a great variety of such information. However, lay people might have difficulties to assess whether a certain article or Web site fits their individual level of understandability. Hence, they might get overwhelmed with the delivered complexity of medical information. In this paper, we present a Web browser plugin, Expertizer that supports users in order to easily assess the expert level of textual medical Web content. The plugin communicates with a Web service, which leverages pre-computed classification models based on a Support Vector Machine.
Collapse
Affiliation(s)
- Richard Zowalla
- Dept. of Medical Informatics, Heilbronn University, Heilbronn, Germany
| | - Martin Wiesner
- Dept. of Medical Informatics, Heilbronn University, Heilbronn, Germany
| | - Daniel Pfeifer
- Dept. of Medical Informatics, Heilbronn University, Heilbronn, Germany
| |
Collapse
|
16
|
Muscat M, Shefer A, Ben Mamou M, Spataru R, Jankovic D, Deshevoy S, Butler R, Pfeifer D. The state of measles and rubella in the WHO European Region, 2013. Clin Microbiol Infect 2014; 20 Suppl 5:12-8. [PMID: 24520948 DOI: 10.1111/1469-0691.12584] [Citation(s) in RCA: 71] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Measles and rubella persist in the World Health Organization European Region despite long-standing and widespread use of vaccines against them. Our aim was to review the epidemiology of measles and rubella in relation to the goal of eliminating these diseases from the Region by 2015. We report on the number of measles and rubella cases by country in 2012 and present an analysis of preliminary measles and rubella surveillance data for 2013. We analysed data of these diseases for 2013 by age group, diagnosis confirmation (clinical, laboratory-confirmed and epidemiologically linked), and vaccination, hospitalization and importation status. We also report on measles-related deaths. For 2012, there were 26,785 [corrected] measles cases and 29,601 rubella cases reported in the Region. For 2013, these figures were 31,520 and 39,367 respectively. Most measles cases in 2013 (96%; n = 30,178) were reported by nine countries: Georgia (7830), Germany (1773), Italy (2216), the Netherlands (2499), Romania (1074), the Russian Federation (2174), Turkey (7404), Ukraine (3308) and the United Kingdom (1900). In 2013, most measles cases were among unvaccinated persons and over one in three patients were aged 20 years and older. For 2013, almost all rubella cases were reported by Poland (n = 38,585; 98%). High population immunity and high-quality surveillance are the cornerstones to eliminate measles and rubella. Without sustained political commitment and accelerated action by Member States and partners, the elimination of measles and rubella in the WHO European Region may not be achieved.
Collapse
Affiliation(s)
- M Muscat
- World Health Organization Regional Office for Europe, Copenhagen, Denmark
| | | | | | | | | | | | | | | |
Collapse
|
17
|
Sprissler C, Belenki D, Maurer H, Aumann K, Pfeifer D, Klein C, Müller TA, Kissel S, Hülsdünker J, Alexandrovski J, Brummer T, Jumaa H, Duyster J, Dierks C. Depletion of STAT5 blocks TEL-SYK-induced APMF-type leukemia with myelofibrosis and myelodysplasia in mice. Blood Cancer J 2014; 4:e240. [PMID: 25148222 PMCID: PMC4219468 DOI: 10.1038/bcj.2014.53] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2014] [Revised: 05/27/2014] [Accepted: 06/12/2014] [Indexed: 12/16/2022] Open
Abstract
The spleen tyrosine kinase (SYK) was identified as an oncogenic driver in a broad spectrum of hematologic malignancies. The in vivo comparison of three SYK containing oncogenes, SYK(wt), TEL-SYK and IL-2-inducible T-cell kinase (ITK)-SYK revealed a general myeloexpansion and the establishment of three different hematologic (pre)diseases. SYK(wt) enhanced the myeloid and T-cell compartment, without leukemia/lymphoma development. ITK-SYK caused lethal T-cell lymphomas and the cytoplasmic TEL-SYK fusion induced an acute panmyelosis with myelofibrosis-type acute myeloid leukemia (AML) with up to 50% immature megakaryoblasts infiltrating bone marrow, spleen and liver, additional MPN features (myelofibrosis and granulocyte expansion) and MDS stigmata with megakaryocytic and erythroid dysplasia. LKS cells were reduced and all subsets (LT/ST/MPP) showed reduced proliferation rates. SYK inhibitor treatment (R788) of diseased TEL-SYK mice reduced leukocytosis, spleen and liver infiltration, enhanced the hematocrit and prolonged survival time, but could not significantly reduce myelofibrosis. Stat5 was identified as a major downstream mediator of TEL-SYK in vitro as well as in vivo. Consequently, targeted deletion of Stat5 in vivo completely abrogated TEL-SYK-induced AML and myelofibrosis development, proving Stat5 as a major driver of SYK-induced transformation. Our experiments highlight the important role of SYK in AML and myelofibrosis and prove SYK and STAT5 inhibitors as potent treatment options for those diseases.
Collapse
MESH Headings
- Animals
- Cell Line
- Gene Deletion
- Intracellular Signaling Peptides and Proteins/genetics
- Intracellular Signaling Peptides and Proteins/metabolism
- Leukemia, Myeloid, Acute/genetics
- Leukemia, Myeloid, Acute/metabolism
- Leukemia, Myeloid, Acute/pathology
- Leukemia, Myeloid, Acute/prevention & control
- Male
- Mice
- Mice, Inbred BALB C
- Myelodysplastic Syndromes/genetics
- Myelodysplastic Syndromes/metabolism
- Myelodysplastic Syndromes/pathology
- Myelodysplastic Syndromes/prevention & control
- Oncogene Proteins, Fusion/genetics
- Oncogene Proteins, Fusion/metabolism
- Primary Myelofibrosis/genetics
- Primary Myelofibrosis/metabolism
- Primary Myelofibrosis/pathology
- Primary Myelofibrosis/prevention & control
- Protein-Tyrosine Kinases/genetics
- Protein-Tyrosine Kinases/metabolism
- Proto-Oncogene Proteins c-ets/genetics
- Proto-Oncogene Proteins c-ets/metabolism
- Repressor Proteins/genetics
- Repressor Proteins/metabolism
- STAT5 Transcription Factor/genetics
- STAT5 Transcription Factor/metabolism
- Syk Kinase
- ETS Translocation Variant 6 Protein
Collapse
Affiliation(s)
- C Sprissler
- Department of Hematology/Oncology, University Medical Center Freiburg, Freiburg, Germany
- University of Freiburg, Schaenzlestrasse 1, Freiburg, Germany
| | - D Belenki
- Department of Hematology/Oncology, University Medical Center Freiburg, Freiburg, Germany
| | - H Maurer
- Department of Hematology/Oncology, University Medical Center Freiburg, Freiburg, Germany
| | - K Aumann
- Department of Pathology, University Medical Center Freiburg, Freiburg, Germany
| | - D Pfeifer
- Department of Hematology/Oncology, University Medical Center Freiburg, Freiburg, Germany
| | - C Klein
- Department of Hematology/Oncology, University Medical Center Freiburg, Freiburg, Germany
| | - T A Müller
- Department of Hematology/Oncology, University Medical Center Freiburg, Freiburg, Germany
| | - S Kissel
- Department of Hematology/Oncology, University Medical Center Freiburg, Freiburg, Germany
| | - J Hülsdünker
- Department of Hematology/Oncology, University Medical Center Freiburg, Freiburg, Germany
| | - J Alexandrovski
- Department of Hematology/Oncology, University Medical Center Freiburg, Freiburg, Germany
| | - T Brummer
- Institut für Molekulare Medizin und Zellforschung, University of Freiburg, Stefan-Meier-Str. 17, Freiburg, Germany
- Centre for Biological Signaling Studies BIOSS, Freiburg, Germany
| | - H Jumaa
- Department of Pathology, University Medical Center Freiburg, Freiburg, Germany
- Institut für Molekulare Medizin und Zellforschung, University of Freiburg, Stefan-Meier-Str. 17, Freiburg, Germany
- Centre for Biological Signaling Studies BIOSS, Freiburg, Germany
| | - J Duyster
- Department of Hematology/Oncology, University Medical Center Freiburg, Freiburg, Germany
| | - C Dierks
- Department of Hematology/Oncology, University Medical Center Freiburg, Freiburg, Germany
- Centre for Biological Signaling Studies BIOSS, Freiburg, Germany
| |
Collapse
|
18
|
Bredel M, Ferrarese R, Harsh GR, Yadav AK, Bug E, Maticzka D, Reichardt W, Masilamani AP, Dai F, Kim H, Hadler M, Scholtens DM, Yu ILY, Beck J, Srinivasasainagendra V, Costa F, Baxan N, Pfeifer D, Elverfeldt DV, Backofen R, Weyerbrock A, Duarte CW, He X, Prinz M, Chandler JP, Vogel H, Chakravarti A, Rich JN, Carro MS. ABERRANT SPLICING OF A BRAIN-ENRICHED ALTERNATIVE EXON ELIMINATES TUMOR SUPPRESSOR FUNCTION AND PROMOTES ONCOGENE FUNCTION DURING BRAIN TUMORIGENESIS. Neuro Oncol 2014. [DOI: 10.1093/neuonc/nou206.71] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
19
|
Wiesner M, Pfeifer D. Health recommender systems: concepts, requirements, technical basics and challenges. Int J Environ Res Public Health 2014; 11:2580-607. [PMID: 24595212 PMCID: PMC3968965 DOI: 10.3390/ijerph110302580] [Citation(s) in RCA: 130] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/03/2013] [Revised: 02/04/2014] [Accepted: 02/08/2014] [Indexed: 11/16/2022]
Abstract
During the last decades huge amounts of data have been collected in clinical databases representing patients' health states (e.g., as laboratory results, treatment plans, medical reports). Hence, digital information available for patient-oriented decision making has increased drastically but is often scattered across different sites. As as solution, personal health record systems (PHRS) are meant to centralize an individual's health data and to allow access for the owner as well as for authorized health professionals. Yet, expert-oriented language, complex interrelations of medical facts and information overload in general pose major obstacles for patients to understand their own record and to draw adequate conclusions. In this context, recommender systems may supply patients with additional laymen-friendly information helping to better comprehend their health status as represented by their record. However, such systems must be adapted to cope with the specific requirements in the health domain in order to deliver highly relevant information for patients. They are referred to as health recommender systems (HRS). In this article we give an introduction to health recommender systems and explain why they are a useful enhancement to PHR solutions. Basic concepts and scenarios are discussed and a first implementation is presented. In addition, we outline an evaluation approach for such a system, which is supported by medical experts. The construction of a test collection for case-related recommendations is described. Finally, challenges and open issues are discussed.
Collapse
Affiliation(s)
- Martin Wiesner
- Department of Medical Informatics, Heilbronn University, Max-Planck-Str. 39, Heilbronn 74081, Germany.
| | - Daniel Pfeifer
- Department of Medical Informatics, Heilbronn University, Max-Planck-Str. 39, Heilbronn 74081, Germany.
| |
Collapse
|
20
|
Hetterich C, Pobiruchin M, Wiesner M, Pfeifer D. How Google Glass could support patients with diabetes mellitus in daily life. Stud Health Technol Inform 2014; 205:298-302. [PMID: 25160194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Even long before it was published, many people regarded Google Glass as a Swiss army knife for nearly every task. There are some fields of application in which the best known wearable device could simplify daily life, such as car navigation or reading recipes. But does this also apply for medicine and health care? This paper will at first explain what Google Glass is and how it works. Afterwards, diabetes mellitus (DM), is discussed. Moreover, we try to answer the question whether a Glass-like device could support and improve people with DM. Therefore, several use cases for Glass-enabled chronic disease care are outlined.
Collapse
Affiliation(s)
| | | | - Martin Wiesner
- Dept. of Medical Informatics, Heilbronn University, Germany
| | - Daniel Pfeifer
- Dept. of Medical Informatics, Heilbronn University, Germany
| |
Collapse
|
21
|
Zowalla R, Wiesner M, Pfeifer D. Automatically Assessing the Expert Degree of Online Health Content using SVMs. Stud Health Technol Inform 2014; 202:48-51. [PMID: 25000012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
More and more people search for health information regarding diseases, diagnoses and treatments over the Web. However, lay people often have difficulties in assessing the understandability of related articles. Therefore, they could benefit from a system, which computes the medical expert degree of a corresponding piece of text in advance. In this paper we present an approach to automatically compute this expert degree using a machine learning approach. For evaluation purposes we constructed a large text corpus and tested our trained text classifier, which is based on Support Vector Machines.
Collapse
Affiliation(s)
- Richard Zowalla
- Dept. of Medical Informatics, Heilbronn University, Heilbronn, Germany
| | - Martin Wiesner
- Dept. of Medical Informatics, Heilbronn University, Heilbronn, Germany
| | - Daniel Pfeifer
- Dept. of Medical Informatics, Heilbronn University, Heilbronn, Germany
| |
Collapse
|
22
|
Wiesner M, Pobiruchin M, Hetterich C, Pfeifer D. GlassAllergy: a Google Glass-based solution to empower patients with skin allergies. Stud Health Technol Inform 2014; 205:548-552. [PMID: 25160245] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
A variety of substances contained in cosmetic products can lead to allergic reactions for certain individuals. The names of such substances are predominantly printed onto a product in small-sized expert language. For this reason, consumers often have difficulties to assess whether some of the ingredients might be harmful for them. Consequently, patients are exposed to a risk of buying a cosmetic product that might cause a minor to severe allergic reaction. A Google Glass-based software solution for consumers suffering from skin allergies is presented. It enables users to check cosmetic products in a mobile context and empowers patients to make informed buying decisions. In particular, the solution could help to avoid or reduce the risk for allergic reactions.
Collapse
Affiliation(s)
- Martin Wiesner
- Dept. of Medical Informatics, Heilbronn University, Germany
| | | | | | - Daniel Pfeifer
- Dept. of Medical Informatics, Heilbronn University, Germany
| |
Collapse
|
23
|
Simunovic F, Steiner D, Pfeifer D, Stark GB, Finkenzeller G, Lampert F. Increased extracellular matrix and proangiogenic factor transcription in endothelial cells after cocultivation with primary human osteoblasts. J Cell Biochem 2013; 114:1584-94. [PMID: 23334902 DOI: 10.1002/jcb.24500] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2012] [Accepted: 01/08/2013] [Indexed: 12/12/2022]
Abstract
The most promising strategies in bone engineering have concentrated on providing sufficient vascularization to support the newly forming tissue. In this context, recent research in the field has focused on studying the complex interactions between bone forming and endothelial cells. Our previous work has demonstrated that direct contact cocultivation of human umbilical vein endothelial cells (HUVECs) with primary human osteoblasts (hOBs) induces the osteogenic phenotype and survival of hOBs. In order to investigate the mechanisms that lead to this effect, we performed microarray gene expression profiling on HUVECs following cocultivation with hOBs. Our data reveal profound transcriptomic changes that are dependent on direct cell contact between these cell populations. Pathway analysis using the MetaCore™ platform and literature research suggested a striking upregulation of transcripts related to extracellular matrix and cell-matrix interactions. Upregulation of a number of major angiogenetic factors confirms previous observations that HUVECs enter a proangiogenic state upon cocultivation with osteoblasts. Interestingly, the downregulated transcripts clustered predominantly around cell cycle-related processes. The microarray data were confirmed by quantitative real-time RT-PCR on selected genes. Taken together, this study provides a platform for further inquiries in complex interactions between endothelial cells and osteoblasts.
Collapse
Affiliation(s)
- F Simunovic
- Department of Plastic and Hand Surgery, Freiburg University Medical Center, Freiburg, Germany
| | | | | | | | | | | |
Collapse
|
24
|
Muscat M, Jankovic D, Deshevoi S, Pfeifer D. Measles and Rubella in the countries of the World Health Organization European Region: an epidemiological assessment. Eur J Public Health 2013. [DOI: 10.1093/eurpub/ckt126.119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
25
|
Muscat M, Jankovic D, Goel A, Butler R, Pfeifer D. [Progress in the elimination of measles and rubella in the WHO European Region]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013; 56:1225-30. [PMID: 23990083 DOI: 10.1007/s00103-013-1797-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Substantial progress has been made in the World Health Organization (WHO) European Region toward reaching the goal of measles and rubella elimination. We analyzed the surveillance data of 2012 on measles and rubella for age-group, diagnosis confirmation status (clinical, laboratory-confirmed and epidemiologically linked), vaccination status, and measles-related deaths. For 2012, there were 23,871 measles cases and 29,361 rubella cases reported in the region, mostly among unvaccinated persons. Almost one in three patients with measles and one in five patients with rubella were aged 20 years and older. In a few countries, widespread outbreaks or indigenous transmission of measles persisted in 2012. While most countries in the region have controlled rubella, a small number still reported a high incidence and several outbreaks. Therefore, more efforts are required to achieve the goal of eliminating measles and rubella in the WHO European Region by 2015, particularly in high-incidence countries. The WHO measles and rubella elimination plan stipulates that all countries should achieve and maintain the required high vaccination coverage while conducting high-quality surveillance.
Collapse
Affiliation(s)
- M Muscat
- WHO Regional Office for Europe, UN City, Marmorvej 51, 2100, Copenhagen Ø, Dänemark.
| | | | | | | | | |
Collapse
|
26
|
Wiesner M, Pfeifer D. Building a widespread public health education system for developing countries in Africa. Stud Health Technol Inform 2013; 190:240-242. [PMID: 23823435] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
Many developing countries struggle to move their health care system into the information age. Millions of people in Africa do not have any access to online resources to satisfy their need for adequate individual health information. Access to high quality content available in public spots could have an immense impact on people's daily life. Our browser-based health education application might help to provide a better understanding of diseases for people in developing countries. We encourage other researchers to adopt our vision for a widespread public health education system in Africa.
Collapse
Affiliation(s)
- Martin Wiesner
- Dept. of Medical Informatics, Heilbronn University, Germany
| | | |
Collapse
|
27
|
Fischer L, Deppert W, Pfeifer D, Stanzel S, Weimer M, Hanjalic-Beck A, Stein A, Straßer M, Zahradnik H, Schaefer W. Potential hazards to embryo implantation: A human endometrial in vitro model to identify unwanted antigestagenic actions of chemicals. Toxicol Appl Pharmacol 2012; 260:232-40. [DOI: 10.1016/j.taap.2012.02.016] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2012] [Revised: 02/22/2012] [Accepted: 02/26/2012] [Indexed: 10/28/2022]
|
28
|
Gehoff A, Kluge JG, Gehoff P, Jurisch D, Pfeifer D, Hinz J, Popov AF. Recurrent strokes under anticoagulation therapy: Sticky platelet syndrome combined with a patent foramen ovale. J Cardiovasc Dis Res 2011; 2:68-70. [PMID: 21716756 PMCID: PMC3120276 DOI: 10.4103/0975-3583.78600] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
The sticky platelet syndrome (SPS) is a congenital disorder characterized by platelet hyperaggregability to epinephrine and/or adenosine diphosphate; this predisposes affected individuals to acute myocardial infarction, ischemic optic neuropathy, recurrent venous thromboembolism, and transient ischemic cerebral attacks and strokes. Here, we describe an unusual case with recurrent cerebrovascular accidents due to SPS, in the presence of a patent foramen ovale (PFO). We report an unusual case of a 56-year-old female patient with a PFO, who suffered from recurrent strokes despite long-term medication with clopidogrel for SPS. The patient underwent successful transcatheter closure of the PFO, and, in addition, she has been placed on low-dose acetylsalicylic acid. After 18-month follow-up, she demonstrated an intact atrial septum without any vegetations on the percutaneous device until today. She has had no further thromboembolic events.
Collapse
Affiliation(s)
- A Gehoff
- Institute of Pathology Nordhessen, Kassel, Germany
| | | | | | | | | | | | | |
Collapse
|
29
|
Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schäffer AA, Noyan F, Perro M, Diestelhorst J, Allroth A, Murugan D, Hätscher N, Pfeifer D, Sykora KW, Sauer M, Kreipe H, Lacher M, Nustede R, Woellner C, Baumann U, Salzer U, Koletzko S, Shah N, Segal AW, Sauerbrey A, Buderus S, Snapper SB, Grimbacher B, Klein C. Early-onset inflammatory bowel disease caused by mutant IL10 receptor. Lab Invest 2010. [PMCID: PMC3007730 DOI: 10.1186/1479-5876-8-s1-i12] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
30
|
Waterhouse M, Pfeifer D, Pantic M, Alf Z, Bertz H, Finke J. Cryptic Genomic Alterations In AML Patients After Allogeneic Hematopoietic Cell Transplantation By SNP DNA Profiling. Biol Blood Marrow Transplant 2010. [DOI: 10.1016/j.bbmt.2009.12.358] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
31
|
McGhee S, Engelhardt K, Winkler S, Sassi A, Woellner C, Lopez-Herrera G, Chen A, Kim H, Lloret MG, Schulze I, Ehl S, Thiel J, Pfeifer D, Veelken H, Niehues T, Siepermann K, Weinspach S, Reisli I, Keles S, Genel F, Kütükçüler N, Camcioglu Y, Somer A, Karakoc-Aydiner E, Barlan I. DOCK8 Deletions and Mutations Are Associated With The Autosomal Recessive Hyper-IgE Phenotype. J Allergy Clin Immunol 2010. [DOI: 10.1016/j.jaci.2010.01.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
32
|
Pantic M, Schroettner P, Pfeifer D, Rawluk J, Denz U, Schmitt-Gräff A, Veelken H, Wäsch R, Engelhardt M. Biclonal origin prevails in concomitant chronic lymphocytic leukemia and multiple myeloma. Leukemia 2010; 24:885-90. [PMID: 20090779 DOI: 10.1038/leu.2009.294] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
|
33
|
Jäger S, Jahnke A, Wilmes T, Adebahr S, Vögtle FN, Delima-Hahn E, Pfeifer D, Berg T, Lübbert M, Trepel M. Leukemia-targeting ligands isolated from phage-display peptide libraries. Leukemia 2007; 21:411-20. [PMID: 17252013 DOI: 10.1038/sj.leu.2404548] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
Ligands specifically binding to leukemia cells may be used for drug targeting, resulting in more effective treatment with less side effects. Little is known about receptors specifically expressed on acute myeloid leukemia (AML) cells or ligands thereof. We selected random phage display peptide libraries on Kasumi-1 AML cells. A peptide with the sequence CPLDIDFYC was enriched. Phage displaying this peptide strongly bound to Kasumi-1 and SKNO-1 cells and binding could be inhibited by the cognate peptide. Both, Kasumi-1 and SKNO-1 cells carry the chromosomal translocation t(8;21), leading to aberrant expression of the fusion protein AML1/ETO. CPLDIDFYC also strongly and specifically bound primary AML1/ETO-positive AML blasts as well as U-937 cells with forced AML1/ETO expression, suggesting that the CPLDIDFYC receptor may be upregulated upon AML1/ETO expression. Gene expression profiling comparing a panel of CPLDIDFYC-binding and CPLDIDFYC-nonbinding cell lines identified a set of potential receptors for the CPLDIDFYC peptide. Further analysis suggested that alpha4beta1 integrin (VLA-4) is the CPLDIDFYC receptor. Finally, we showed that the CPLDIDFYC-phage is internalized upon receptor binding, suggesting that the CPLDIDFYC-receptor-ligand interaction may be exploitable for targeting drugs or gene therapy vectors to leukemia cells carrying the suitable receptor.
Collapse
MESH Headings
- Acute Disease
- Aged
- Cell Line, Tumor/metabolism
- Chromosomes, Human, Pair 21/genetics
- Chromosomes, Human, Pair 21/ultrastructure
- Chromosomes, Human, Pair 8/genetics
- Chromosomes, Human, Pair 8/ultrastructure
- Core Binding Factor Alpha 2 Subunit/genetics
- Core Binding Factor Alpha 2 Subunit/physiology
- Drug Delivery Systems
- Drug Screening Assays, Antitumor
- Endocytosis
- Female
- Gene Expression Profiling
- Genetic Therapy
- Humans
- Integrin alpha4beta1/antagonists & inhibitors
- Integrin alpha4beta1/metabolism
- Leukemia, Myeloid/genetics
- Leukemia, Myeloid/pathology
- Leukemia, Myeloid, Acute/genetics
- Leukemia, Myeloid, Acute/pathology
- Ligands
- Neoplasm Proteins/genetics
- Neoplasm Proteins/physiology
- Neoplastic Stem Cells/metabolism
- Oligopeptides/isolation & purification
- Oligopeptides/metabolism
- Oligopeptides/pharmacology
- Oncogene Proteins, Fusion/genetics
- Oncogene Proteins, Fusion/physiology
- Peptide Library
- Protein Binding
- RUNX1 Translocation Partner 1 Protein
- Receptors, Drug/antagonists & inhibitors
- Receptors, Drug/metabolism
- Translocation, Genetic
Collapse
Affiliation(s)
- S Jäger
- Department of Hematology and Oncology, University of Freiburg Medical Center, Freiburg, Germany
| | | | | | | | | | | | | | | | | | | |
Collapse
|
34
|
Pfeifer D, Hoffmann K, Hoffmann A, Monte C, Resch-Genger U. The Calibration Kit Spectral Fluorescence Standards—A Simple and Certified Tool for the Standardization of the Spectral Characteristics of Fluorescence Instruments. J Fluoresc 2006; 16:581-7. [PMID: 16791494 DOI: 10.1007/s10895-006-0086-8] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2005] [Accepted: 02/21/2006] [Indexed: 10/24/2022]
Abstract
With the Calibration Kit Spectral Fluorescence Standards BAM-F001-BAM-F005, we developed a simple tool for the characterization of the relative spectral responsivity and the long-term stability of the emission channel of fluorescence instruments under routine measurement conditions thereby providing the basis for an improved comparability of fluorescence measurements and eventually standardization. This first set of traceable fluorescence standards, which links fluorescence measurements to the spectral radiance scale in the spectral range of 300-770 nm and has been optimized for spectrofluorometers, can be employed for different measurement geometries and can be adapted to different fluorescence techniques with proper consideration of the underlying measurement principles.
Collapse
Affiliation(s)
- D Pfeifer
- Federal Institute for Materials Research and Testing, Working Group Optical Spectroscopy, Division I.5, Berlin, Germany
| | | | | | | | | |
Collapse
|
35
|
Hollandt J, Taubert RD, Seidel J, Resch-Genger U, Gugg-Helminger A, Pfeifer D, Monte C, Pilz W. Traceability in Fluorometry—Part I: Physical Standards. J Fluoresc 2005; 15:301-13. [PMID: 15986155 DOI: 10.1007/s10895-005-2628-x] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2004] [Accepted: 02/08/2005] [Indexed: 11/29/2022]
Abstract
The inter-instrument, inter-laboratory, and long-term comparability of fluorescence data requires the correction of the measured emission and excitation spectra for the wavelength- and polarization-dependent spectral irradiance of the excitation channel at the sample position and the spectral responsivity of the emission channel employing procedures that guarantee traceability to the respective primary standards. In this respect the traceability chain of fluorometry is discussed from a radiometrist's point of view. This involves, in a first step, the realization of the spectral radiance scale, based on the blackbody radiator and electron storage ring, and the spectral responsivity scale, based on the cryogenic radiometer and their control via key comparisons of the national metrology institutes. In a second step, the characterization including state-of-the art uncertainties of the respective source and detector transfer standards such as tungsten strip lamps, integrating sphere radiators, and trap detectors used to disseminate these radiometric quantities to users of spectroscopic techniques is presented.
Collapse
Affiliation(s)
- J Hollandt
- Physikalisch-Technische Bundesanstalt, Abbestrasse 2-12, D-10587 Berlin, Germany.
| | | | | | | | | | | | | | | |
Collapse
|
36
|
Resch-Genger U, Pfeifer D, Monte C, Pilz W, Hoffmann A, Spieles M, Rurack K, Hollandt J, Taubert D, Schönenberger B, Nording P. Traceability in Fluorometry: Part II. Spectral Fluorescence Standards. J Fluoresc 2005; 15:315-36. [PMID: 15986156 DOI: 10.1007/s10895-005-2629-9] [Citation(s) in RCA: 93] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2004] [Accepted: 02/24/2004] [Indexed: 11/28/2022]
Abstract
The need for the traceable characterization of fluorescence instruments is emphasized from a chemist's point of view, focusing on spectral fluorescence standards for the determination of the wavelength- and polarization-dependent relative spectral responsivity and relative spectral irradiance of fluorescence measuring systems, respectively. In a first step, major sources of error of fluorescence measurements and instrument calibration are revealed to underline the importance of this issue and to illustrate advantages and disadvantages of physical and chemical transfer standards for generation of spectral correction curves. Secondly, examples for sets of traceable chemical emission and excitation standards are shown that cover a broad spectral region and simple procedures for the determination of corrected emission spectra with acceptable uncertainties are presented. With proper consideration of the respective measurement principle and geometry, these dye-based characterization procedures can be not only applied to spectrofluorometers but also to other types of fluorescence measuring systems and even to Raman spectrometers.
Collapse
Affiliation(s)
- U Resch-Genger
- Federal Institute for Materials Research and Testing, Working Group Optical Spectroscopy, Division I.3, Berlin, Germany.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Fanghänel E, Böckelmann J, Grossmann N, Pfeifer D. Synthese von 5-Nitro-2,3-dihydrobenzo(b)furanen aus 2-Methylen-triethyl-ammonio-4-nitrophenolat und 2-Chlor-1,3-dicarbonylverbindungen. ACTA ACUST UNITED AC 2004. [DOI: 10.1002/prac.19863280510] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
38
|
Baumann H, Müller U, Pfeifer D, Timpe HJ. Lichtinitiierte Polymer- und Polymerisationsreaktionen. III. Photoinduzierte Zersetzung von Aryldiazoniumsalzen durch Benzoinderivate. ACTA ACUST UNITED AC 2004. [DOI: 10.1002/prac.19823240206] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
39
|
Pop R, Conz C, Lindenberg KS, Blesson S, Schmalenberger B, Briault S, Pfeifer D, Scherer G. Screening of the 1 Mb SOX9 5' control region by array CGH identifies a large deletion in a case of campomelic dysplasia with XY sex reversal. J Med Genet 2004; 41:e47. [PMID: 15060123 PMCID: PMC1735745 DOI: 10.1136/jmg.2003.013185] [Citation(s) in RCA: 66] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
40
|
Bagheri-Fam S, Ferraz C, Demaille J, Scherer G, Pfeifer D. Comparative genomics of the SOX9 region in human and Fugu rubripes: conservation of short regulatory sequence elements within large intergenic regions. Genomics 2001; 78:73-82. [PMID: 11707075 DOI: 10.1006/geno.2001.6648] [Citation(s) in RCA: 74] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
Campomelic dysplasia (CD), a human skeletal malformation syndrome with XY sex reversal, is caused by heterozygous mutations in and around the gene SOX9. SOX9 has an extended 5' control region, as indicated by CD translocation breakpoints scattered over 1 Mb proximal to SOX9 and by expression data from mice transgenic for human SOX9-spanning yeast artificial chromosomes. To identify long-range regulatory elements within the SOX9 5' control region, we compared approximately 3.7 Mb and 195 kb of sequence around human and Fugu rubripes SOX9, respectively. We identified only seven and five protein-coding genes in the human and F. rubripes sequences, respectively. Four of the F. rubripes genes have been mapped in humans; all reside on chromosome 17 but show extensive intrachromosomal gene shuffling compared with the gene order in F. rubripes. In both species, very large intergenic distances separate SOX9 from its directly flanking genes: 2 Mb and 500 kb on either side of SOX9 in humans, and 68 and 97 kb on either side of SOX9 in F. rubripes. Comparative sequence analysis of the intergenic regions revealed five conserved elements, E1-E5, up to 290 kb 5' to human SOX9 and up to 18 kb 5' to F. rubripes SOX9, and three such elements, E6-E8, 3' to SOX9. Where available, mouse sequences confirm conservation of the elements. From the yeast artificial chromosome transgenic data, elements E3-E5 are candidate enhancers for SOX9 expression in limb and vertebral column, and 8 of 10 CD translocation breakpoints separate these elements from SOX9.
Collapse
Affiliation(s)
- S Bagheri-Fam
- Institute of Human Genetics and Anthropology, University of Freiburg, Breisacherstr. 33, Freiburg, D-79106, Germany
| | | | | | | | | |
Collapse
|
41
|
Radoncić E, Delmis J, Pfeifer D, Mayer D. Successful treatment of alloimmune thrombocytopenia using corticosteroid therapy in a woman with two consecutive neonatal deaths--case report. Acta Med Croatica 2001; 54:125-7. [PMID: 11268790] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
Alloimmune thrombocytopenia is a serious fetal disorder resulting from platelet-antigen incompatibility between the mother and the fetus. In mild cases, the diagnosis is usually made upon detection of neonatal thrombocytopenia, but serious consequences such as fetal intracranial hemorrhage and/or unexplained fetal death may complicate the disorder. Various treatment modalities are suggested in the management of alloimmune thrombocytopenia, however, none has yet been confirmed as obviously superior. We report on the successful use of corticosteroids during pregnancy in a woman with a history of two consecutive neonatal deaths due to severe thrombocytopenia and HPA 5b platelet-specific antigen incompatibility.
Collapse
Affiliation(s)
- E Radoncić
- Modern Medical Centre, Schoool of Medicine, University of Zagreb, Zagreb, Croatia
| | | | | | | |
Collapse
|
42
|
McCune JS, Oertel MD, Pfeifer D, Houston SA, Bingham A, Sawyer WT, Lindley CM. Evaluation of outcomes in converting from intravenous ondansetron to oral granisetron: an observational study. Ann Pharmacother 2001; 35:14-20. [PMID: 11197579 DOI: 10.1345/aph.10014] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Abstract
OBJECTIVE To describe a systematic evaluation of the outcomes associated with revising institutional guidelines for the prevention of acute chemotherapy-induced nausea and vomiting (CINV) to promote cost-effective use of the serotonin (5-HT3) antagonists. METHODS The 5-HT3 antagonist of choice in the antiemetic guidelines was revised from intravenous ondansetron to oral granisetron in August 1995. Patient assessments were conducted immediately prior to (Period 1) and after (Period 2) guideline revision using validated questionnaires. The effectiveness of the two 5-HT3 antagonists were compared and reported to the prescribing oncologists. Outcomes were assessed one year after guideline revision (Period 3) using identical methods. RESULTS No difference was found in the rate of total control (no emesis, no nausea) between patients receiving oral granisetron (60%) and intravenous ondansetron (56%) (p = 0.408, Period 1 vs. 2). Nausea severity, the number of emesis episodes, and use of rescue antiemetics were also equivalent. Prescriber compliance with using the 5-HT3 antagonist of choice and dose increased from 48% to 61% following adoption of oral granisetron. By Period 3, compliance increased to 78%, and satisfactory control of acute CINV was again documented. The costs for prevention of acute CINV decreased from $107 in Period 1 (intravenous ondansetron only) to $65 in Period 3 (oral granisetron). CONCLUSIONS Outcomes associated with use of oral granisetron and intravenous ondansetron were equivalent in this patient population. Guideline revision and outcome documentation by the oncology pharmacists resulted in increased compliance with institution guidelines and a 40% cost savings.
Collapse
Affiliation(s)
- J S McCune
- School of Pharmacy, University of Washington, Seattle, WA, USA
| | | | | | | | | | | | | |
Collapse
|
43
|
|
44
|
Abstract
A case of a 24-year-old multigravida, with dry cough, dyspnea, fatigue, and weight loss with normal foetal growth rate is reviewed. Upon admission the patient suddenly became tachycardic, tachypnoic, cyanotic, followed by a non-palpable peripheral pulse, and asystole unresponsive to resuscitation. The autopsy revealed massive pulmonary trophoblastic embolism, bilateral pregnancy luteoma, and accelerated placental maturation. Trophoblastic embolism should be taken into consideration whenever cardiorespiratory emergency develops during pregnancy.
Collapse
Affiliation(s)
- J Delmis
- Department of Obstetrics and Gynaecology, University of Zagreb Medical School, Petrova 13, HR-10000, Zagreb, Croatia.
| | | | | | | | | |
Collapse
|
45
|
Pfeifer D, Poulat F, Holinski-Feder E, Kooy F, Scherer G. The SOX8 gene is located within 700 kb of the tip of chromosome 16p and is deleted in a patient with ATR-16 syndrome. Genomics 2000; 63:108-16. [PMID: 10662550 DOI: 10.1006/geno.1999.6060] [Citation(s) in RCA: 51] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
SOX proteins are transcription factors that are characterized by a common DNA-binding motif known as the HMG domain. We describe the 5. 4-kb human SOX8 gene that codes for a 446-amino-acid protein and that is expressed strongly in brain and less abundantly in other tissues. SOX8 shows an overall identity of 47% to SOX9 and SOX10. The latter two possess a C-terminal transactivation domain, whereas in SOX8, this domain is located in the central part of the protein. We have mapped SOX8 within 700 kb of the telomeric repeats of band 16p13.3. Hemizygosity for 1 Mb from this region causes the ATR-16 syndrome characterized by alpha-thalassemia and mental retardation. We show that SOX8 is deleted in an ATR-16 patient, and from its location, we deduce that it should be deleted in all previously described cases. Thus, SOX8 is a good candidate gene contributing to the mental retardation phenotype seen in ATR-16 patients.
Collapse
Affiliation(s)
- D Pfeifer
- Institute of Human Genetics and Anthropology, University of Freiburg, Freiburg, Germany
| | | | | | | | | |
Collapse
|
46
|
Pfeifer D, Kist R, Dewar K, Devon K, Lander ES, Birren B, Korniszewski L, Back E, Scherer G. Campomelic dysplasia translocation breakpoints are scattered over 1 Mb proximal to SOX9: evidence for an extended control region. Am J Hum Genet 1999; 65:111-24. [PMID: 10364523 PMCID: PMC1378081 DOI: 10.1086/302455] [Citation(s) in RCA: 158] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
Campomelic dysplasia (CD), a skeletal malformation syndrome with or without XY sex reversal, is usually caused by mutations within the SOX9 gene on distal 17q. Several CD translocation and inversion cases have been described with breakpoints outside the coding region, mapping to locations >130 kb proximal to SOX9. Such cases are generally less severely affected than cases with SOX9 coding-region mutations, as is borne out by three new translocation cases that we present. We have cloned the region extending 1.2 Mb upstream of the SOX9 gene in overlapping bacterial-artificial-chromosome and P1-artificial-chromosome clones and have established a restriction map with rare-cutter enzymes. With sequence-tagged-site-content mapping in somatic-cell hybrids, as well as with FISH, we have precisely mapped the breakpoints of the three new and of three previously described CD cases. The six CD breakpoints map to an interval that is 140-950 kb proximal to the SOX9 gene. With exon trapping, we could isolate five potential exons from the YAC 946E12 that spans the region, four of which could be placed in the contig in the vicinity of the breakpoints. They show the same transcriptional orientation, but only two have an open reading frame (ORF). We failed to detect expression of these fragments in several human and mouse cDNA libraries, as well as on northern blots. Genomic sequence totaling 1,063 kb from the SOX9 5'-flanking region was determined and was analyzed by the gene-prediction program GENSCAN and by a search of dbEST and other databases. No genes or transcripts could be identified. Together, these data suggest that the chromosomal rearrangements most likely remove one or more cis-regulatory elements from an extended SOX9 control region.
Collapse
Affiliation(s)
- D Pfeifer
- Institute of Human Genetics and Anthropology, University of Freiburg, Freiburg, Germany
| | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Ivanisević M, Buković D, Starcević V, Djelmis J, Pfeifer D. Influence of hyperglycemia on early embryonal growth in IDDM pregnant women. Coll Antropol 1999; 23:183-8. [PMID: 10402721] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]
Abstract
The association between maternal diabetes mellitus and congenital anomalies is well established. Congenital malformations in the offspring of diabetic mothers account for approximately forty percent of perinatal deaths. The aim of the study was to identify incidence of early embryonal delay in diabetic and normal pregnancies, and to examine relationship between the HbA1c values and early embryonal growth delay. One hundred twenty IDDM and fifty and four healthy women enrolled into the study. Pregnancy duration was confirmed by beta-HCG measurements within a fortnight from the missed menstrual period. No statistical difference was detected between the studied groups for gestational age, prepregnancy weight, newborns' birthweight and sex. The risk of spontaneous abortion in IDDM pregnancy with delayed embryonal growth was eight times higher than in IDDM pregnancies with normal growth pattern. No fetal malformations were determined in fetuses or newborns of either groups. The mean value and standard deviation of HbA1c in the IDDM patients with normal embryonic growth was 7.3 +/- 1.5%, and in the group of early embryonic growth, delay 9.39 +/- 2.37% respectively (F = 7.79; p = 0.006). This study confirmed the relationship between embryonal growth, spontaneous abortions and abnormal metabolic control of IDDM pregnancies.
Collapse
Affiliation(s)
- M Ivanisević
- Department of Obstetric and Gynecology, School of Medicine, University of Zagreb, Croatia
| | | | | | | | | |
Collapse
|
48
|
Djelmis J, Buković D, Pfeifer D, Ivanisević M. Ponderal index and disproportionate fetal growth in IDDM pregnancies. Coll Antropol 1998; 22:491-5. [PMID: 9887605] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/09/2023]
Abstract
Disproportionate macrosomia refers to excessive weight characterized by a high weight/length ratio. Disproportionate macrosomia is associated with an increased likelihood of neonatal complications. The aim of the study was to investigate incidence of ponderal indexes and disproportionate fetal growth rate in newborns originating from IDDM and healthy pregnancies. 144 IDDM pregnancies and 432 uneventful pregnancies with normal findings of oral glucose tolerance test were studied, and matched 1:3 for gestational age, sex of newborn, mothers's parity and year of delivery. The pregnancies selected terminated between 30-40th gestational week and resulted with live birth. Mean birth weight (+/- SD) in IDDM group was 3558 +/- 817.6 compared to 3132.4 +/- 534.4 grams of control group (F = 51.49; p < 0.001), mean birth length was 49.8 +/- 3.5 vrs 49.1 +/- 2.5 (F = 8.55; p < 0.005), mean gestation age by examination for both study groups 37.9 +/- 1.9, mean ponderal index of IDDM group was 2.82 +/- 0.28 vrs. 2.63 +/- 0.24 (F = 64.52; p < 0.001) of control group, rate of Apgar score < 7 was 21.14% vrs. 5.08% (chi 2 = 30.30; p < 0.001). 53.4% of IDDMs had macrosomia compared with 8.33% of control infants (chi 2 = 140.25; p < 0.001), and 35.24% of IDDMs had disproportionate macrosomia compared with 5.79% of control infants. Significantly higher rate of both proportionally and disproportionally grown infants with macrosomia was found among IDDMs than among control infants. The rate of disproportionate macrosomic infants significantly differ among study group.
Collapse
Affiliation(s)
- J Djelmis
- Department of Obstetrics and Gynaecology, School of Medicine, University of Zagreb, Croatia
| | | | | | | |
Collapse
|
49
|
Pusch C, Hustert E, Pfeifer D, Südbeck P, Kist R, Roe B, Wang Z, Balling R, Blin N, Scherer G. The SOX10/Sox10 gene from human and mouse: sequence, expression, and transactivation by the encoded HMG domain transcription factor. Hum Genet 1998; 103:115-23. [PMID: 9760192 DOI: 10.1007/s004390050793] [Citation(s) in RCA: 99] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
The SOX genes form a gene family related by homology to the high-mobility group (HMG) box region of the testis-determining gene SRY. We have cloned and sequenced the SOX10 and Sox10 genes from human and mouse, respectively. Both genes encode proteins of 466 amino acids with 98% sequence identity. Significant expression of the 2.9-kb human SOX10 mRNA is observed in fetal brain and in adult brain, heart, small intestine and colon. Strong expression of Sox10 occurs throughout the peripheral nervous system during mouse embryonic development. SOX10 shows an overall amino acid sequence identity of 59% to SOX9. Like SOX9, SOX10 has a potent transcription activation domain at its C-terminus and is therefore likely to function as a transcription factor. Whereas SOX9 maps to 17q, a SOX10 cosmid has previously been mapped by us to the region 22q13.1. Mutations in SOX10 have recently been identified as one cause of Waardenburg-Hirschsprung disease in humans, while a Sox10 mutation underlies the mouse mutant Dom, a murine Hirschsprung model.
Collapse
Affiliation(s)
- C Pusch
- Institute of Anthropology and Human Genetics, University of Tübingen, Germany
| | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Djelmis J, Buković D, Ivanisević M, Kovacević V, Pfeifer D. Effects of preeclampsia and eclampsia on cord blood coagulation tests. Coll Antropol 1998; 22:113-7. [PMID: 10097426] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/11/2023]
Abstract
Blood coagulation tests were determined in fifty-three paired umbilical cord blood and maternal venous blood samples originating from term singleton vaginal cephalic deliveries. The index group comprised seventeen deliveries complicated by preeclampsia or eclampsia, and the control group comprised thirty-six healthy women with uneventful pregnancies and deliveries. Mean values obtained from the coagulation and fibrinolytic assays did not significantly differ between study groups, except for antithrombin III levels in index group of neonates, which were significantly lower. Comparison of coagulation and fibrinolytic characteristics between mothers and their neonates produced expected level of difference due to immaturity of their haemostatic mechanisms. We found alterations in maternal blood coagulation and fibrinolysis and evidence of increased intravascular coagulation with severe preeclampsia and IUGR.
Collapse
Affiliation(s)
- J Djelmis
- Department of Obstetrics and Gynaecology, Medical School in Zagreb, Croatia
| | | | | | | | | |
Collapse
|